Teligent, Inc. TLGTQ OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

25/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Teligent, Inc. (TLGTQ) reported total assets of $87.79M and total liabilities of $197.94M for fiscal year 2020, resulting in total equity of $-110.15M.

The company held $5.95M in cash and short-term investments. Total debt stood at $162.64M, with net debt of $156.7M. The Debt-to-Equity (D/E) ratio was -1.48 (conservative).

Current ratio is 1.92, indicating strong short-term liquidity.

Criteria supported by this page:

HEALTH (100/100, Pass) — Debt-to-Equity of -1.48, current ratio of 1.92 — balance sheet is strong
MOAT (0/100) — Total assets $87.79M and equity $-110.15M support the company's competitive scale

Overall SharesGrow Score: 24/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

25/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

0/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Teligent, Inc. Balance Sheet History

Metric	FY2020	FY2019	FY2018	FY2017
Total Assets	$87.79M	$206.91M	$190.89M	$189.99M
Total Liabilities	$197.94M	$212.21M	$172.47M	$145.23M
Total Debt	$162.64M	$186.82M	$153.98M	$120.98M
Cash & Investments	$5.95M	$15.51M	$9.71M	$26.69M
Total Stockholders Equity	$-110.15M	$-5.31M	$18.42M	$44.75M